NF-kappaB_NN
regulates_VBZ
Fas\/APO_NNP
-1_CD
\/_:
CD95_NN
-_:
and_CC
TCR-mediated_JJ
apoptosis_NN
of_IN
T_NN
lymphocytes_NNS
._.

The_DT
maintenance_NN
of_IN
lymphocyte_NN
homeostasis_NN
by_IN
apoptosis_NN
is_VBZ
a_DT
critical_JJ
regulatory_JJ
mechanism_NN
in_IN
the_DT
normal_JJ
immune_JJ
system_NN
._.

The_DT
transcription_NN
factor_NN
NF-kappaB_NN
has_VBZ
been_VBN
shown_VBN
to_TO
play_VB
a_DT
role_NN
in_IN
protecting_VBG
cells_NNS
against_IN
death_NN
mediated_VBN
by_IN
TNF_NN

We_PRP
show_VBP
here_RB
that_IN
NF-kappaB_NN
also_RB
has_VBZ
a_DT
role_NN
in_IN
regulating_VBG
Fas\/APO_NNP
-1_CD
\/_:
CD95-mediated_JJ
death_NN
,_,
a_DT
major_JJ
pathway_NN
of_IN
peripheral_JJ
T_NN
cell_NN
death_NN
._.

Transfection_NN
of_IN
Jurkat_NN
cells_NNS
with_IN
the_DT
NF-kappaB_NN
subunits_NNS
p50_NN
and_CC
p65_NN
confers_VBZ
resistance_NN
against_IN
Fas-mediated_JJ
apoptosis_NN
._.

Reciprocally_RB
,_,
inhibition_NN
of_IN
NF-kappaB_NN
activation_NN
by_IN
a_DT
soluble_JJ
peptide_NN
inhibitor_NN
or_CC
a_DT
dominant_JJ
form_NN
of_IN
the_DT
NF-kappaB_NN
inhibitor_NN
,_,
IkappaB_NN
,_,
makes_VBZ
the_DT
cells_NNS
more_RBR
susceptible_JJ
to_TO
Fas-mediated_JJ
apoptosis_NN
._.

Furthermore_RB
,_,
inhibition_NN
of_IN
NF-kappaB_NN
activation_NN
by_IN
a_DT
soluble_JJ
peptide_NN
inhibitor_NN
rendered_VBD
a_DT
T_NN
cell_NN
hybridoma_NN
more_RBR
susceptible_JJ
to_TO
TCR-mediated_JJ
apoptosis_NN
._.

Correspondingly_RB
,_,
transfection_NN
of_IN
p50_NN
and_CC
p65_NN
provided_VBD
considerable_JJ
protection_NN
from_IN
TCR-mediated_JJ
apoptosis_NN
._.

These_DT
observations_NNS
were_VBD
corroborated_VBN
by_IN
studies_NNS
on_IN
Fas-mediated_JJ
death_NN
in_IN
primary_JJ
T_NN
cells_NNS
._.

Concanavalin_NN
A-activated_JJ
cycling_NN
T_NN
cell_NN
blasts_NNS
from_IN
mice_NNS
that_WDT
are_VBP
transgenic_JJ
for_IN
the_DT
dominant_JJ
IkappaB_NN
molecule_NN
have_VBP
increased_VBN
sensitivity_NN
to_TO
Fas-mediated_JJ
apoptosis_NN
,_,
associated_VBN
with_IN
a_DT
down-regulation_NN
of_IN
NF-kappaB_NN
complexes_NNS
in_IN
the_DT
nucleus_NN
._.

In_IN
addition_NN
,_,
blocking_VBG
TNF_NN
,_,
itself_PRP
a_DT
positive_JJ
regulator_NN
of_IN
NF-kappaB_NN
,_,
with_IN
neutralizing_VBG
antibodies_NNS
renders_VBZ
the_DT
cells_NNS
more_RBR
susceptible_JJ
to_TO
anti-Fas-mediated_JJ
apoptosis_NN
._.

In_IN
summary_NN
,_,
our_PRP$
results_NNS
provide_VBP
compelling_JJ
evidence_NN
that_IN
NF-kappaB_NN
protects_VBZ
against_IN
Fas-mediated_JJ
death_NN
and_CC
is_VBZ
likely_JJ
to_TO
be_VB
an_DT
important_JJ
regulator_NN
of_IN
T_NN
cell_NN
homeostasis_NN
and_CC
tolerance_NN
._.

